Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Examine Value Of Robo Advisor Performance Relative To Fees to see how fee structures influence long-term ROI and value.
23,313 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
After a steep slide, Novo Nordisk has shown fresh momentum. But can the rebound sustain, or is it just a temporary bo...
In a market that rewards patience, a true one-stock opportunity can transform a retirement plan. This guide shows how...
Pershing Square signals a bold bet by leaning into Microsoft as the AI and cloud wave reshapes enterprise tech. The m...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Discover what Universal (UVV) 2026 earnings mean for investors. This plain-English guide breaks down performance driv...
A top executive recently disclosed selling a sizable block of Qualys stock. This article explains how to interpret in...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
When the Fed holds rates, investors often look to the next move. But for Costco stock, a steady policy backdrop may b...